Study of Memantine to Treat Huntington's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 23, 2004

Primary Completion Date

October 28, 2009

Study Completion Date

October 28, 2009

Conditions
Huntington's Disease
Interventions
DRUG

Memantine

10 mg BID x 3 months

Trial Locations (3)

21287

Johns Hopkins Hospital, Baltimore

66160

University of Kansas Medical Center, Kansas City

92037

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Jody Corey-Bloom, MD, PhD

OTHER

NCT00652457 - Study of Memantine to Treat Huntington's Disease | Biotech Hunter | Biotech Hunter